To distinguish between these two subtypes, immunohistochemical markers, such as diffuse Ber-EP4 and BCL2 staining are typical of basal cell carcinoma, while diffuse CDKN2A and SOX2 expressions are almost exclusively associated with basaloid squamous cell carcinoma. The gene discussed is CDKN2A; the disease is basaloid squamous cell carcinoma.